FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024043772> ?p ?o ?g. }

• W3024043772 endingPage "e0233032" @default.
• W3024043772 startingPage "e0233032" @default.
• W3024043772 abstract "Mucopolysaccharidoses are a class of lysosomal storage diseases, characterized by enzymatic deficiency in the degradation of specific glycosaminoglycans (GAG). Pathological accumulation of excess GAG leads to multiple clinical symptoms with systemic character, most severely affecting bones, muscles and connective tissues. Current therapies include periodic intravenous infusion of supplementary recombinant enzyme (Enzyme Replacement Therapy–ERT) or bone marrow transplantation. However, ERT has limited efficacy due to poor penetration in some organs and tissues. Here, we investigated the potential of the β-D-xyloside derivative odiparcil as an oral GAG clearance therapy for Maroteaux–Lamy syndrome (Mucopolysaccharidosis type VI, MPS VI). In vitro, in bovine aortic endothelial cells, odiparcil stimulated the secretion of sulphated GAG into culture media, mainly of chondroitin sulphate (CS) /dermatan sulphate (DS) type. Efficacy of odiparcil in reducing intracellular GAG content was investigated in skin fibroblasts from MPS VI patients where odiparcil was shown to reduce efficiently the accumulation of intracellular CS with an EC50 in the range of 1 μM. In vivo, in wild type rats, after oral administrations, odiparcil was well distributed, achieving μM concentrations in MPS VI disease-relevant tissues and organs (bone, cartilage, heart and cornea). In MPS VI Arylsulphatase B deficient mice (Arsb-), after chronic oral administration, odiparcil consistently stimulated the urinary excretion of sulphated GAG throughout the treatment period and significantly reduced tissue GAG accumulation in liver and kidney. Furthermore, odiparcil diminished the pathological cartilage thickening observed in trachea and femoral growth plates of MPS VI mice. The therapeutic efficacy of odiparcil was similar in models of early (treatment starting in juvenile, 4 weeks old mice) or established disease (treatment starting in adult, 3 months old mice). Our data demonstrate that odiparcil effectively diverts the synthesis of cellular glycosaminoglycans into secreted soluble species and this effect can be used for reducing cellular and tissue GAG accumulation in MPS VI models. Therefore, our data reveal the potential of odiparcil as an oral GAG clearance therapy for MPS VI patients." @default.
• W3024043772 created "2020-05-21" @default.
• W3024043772 creator A5010285605 @default.
• W3024043772 creator A5016492304 @default.
• W3024043772 creator A5019974900 @default.
• W3024043772 creator A5031445633 @default.
• W3024043772 creator A5036101233 @default.
• W3024043772 creator A5043523088 @default.
• W3024043772 creator A5045906192 @default.
• W3024043772 creator A5070305851 @default.
• W3024043772 creator A5076023371 @default.
• W3024043772 creator A5079115379 @default.
• W3024043772 creator A5089895034 @default.
• W3024043772 date "2020-05-15" @default.
• W3024043772 modified "2023-10-04" @default.
• W3024043772 title "Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models" @default.
• W3024043772 cites W1418744509 @default.
• W3024043772 cites W1503990525 @default.
• W3024043772 cites W1505556128 @default.
• W3024043772 cites W1520513696 @default.
• W3024043772 cites W1881137596 @default.
• W3024043772 cites W1926155335 @default.
• W3024043772 cites W1955765029 @default.
• W3024043772 cites W1964757715 @default.
• W3024043772 cites W1971262847 @default.
• W3024043772 cites W1971770267 @default.
• W3024043772 cites W1972673555 @default.
• W3024043772 cites W1976196359 @default.
• W3024043772 cites W1976280564 @default.
• W3024043772 cites W1977239535 @default.
• W3024043772 cites W1978317129 @default.
• W3024043772 cites W1980579070 @default.
• W3024043772 cites W1981972291 @default.
• W3024043772 cites W1985635131 @default.
• W3024043772 cites W1985801121 @default.
• W3024043772 cites W1986515416 @default.
• W3024043772 cites W1988681265 @default.
• W3024043772 cites W1995580605 @default.
• W3024043772 cites W1996762971 @default.
• W3024043772 cites W2000598899 @default.
• W3024043772 cites W2003928141 @default.
• W3024043772 cites W2003993144 @default.
• W3024043772 cites W2010472479 @default.
• W3024043772 cites W2013005253 @default.
• W3024043772 cites W2023990383 @default.
• W3024043772 cites W2035161172 @default.
• W3024043772 cites W2046737902 @default.
• W3024043772 cites W2050557934 @default.
• W3024043772 cites W2053885924 @default.
• W3024043772 cites W2055122580 @default.
• W3024043772 cites W2063973811 @default.
• W3024043772 cites W2073929542 @default.
• W3024043772 cites W2083048616 @default.
• W3024043772 cites W2090963136 @default.
• W3024043772 cites W2095713688 @default.
• W3024043772 cites W2110102431 @default.
• W3024043772 cites W2120817267 @default.
• W3024043772 cites W2124364276 @default.
• W3024043772 cites W2124970277 @default.
• W3024043772 cites W2132361772 @default.
• W3024043772 cites W2132845902 @default.
• W3024043772 cites W2141793986 @default.
• W3024043772 cites W2154079303 @default.
• W3024043772 cites W2155249281 @default.
• W3024043772 cites W2168225099 @default.
• W3024043772 cites W2172020254 @default.
• W3024043772 cites W2222593537 @default.
• W3024043772 cites W2236698265 @default.
• W3024043772 cites W2364999181 @default.
• W3024043772 cites W2546540311 @default.
• W3024043772 cites W2568101683 @default.
• W3024043772 cites W2740130936 @default.
• W3024043772 cites W2766751348 @default.
• W3024043772 cites W2802813997 @default.
• W3024043772 cites W2803817646 @default.
• W3024043772 cites W2885768393 @default.
• W3024043772 cites W2951642052 @default.
• W3024043772 cites W3000310253 @default.
• W3024043772 cites W4211029489 @default.
• W3024043772 cites W4245814297 @default.
• W3024043772 doi "https://doi.org/10.1371/journal.pone.0233032" @default.
• W3024043772 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7228089" @default.
• W3024043772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32413051" @default.
• W3024043772 hasPublicationYear "2020" @default.
• W3024043772 type Work @default.
• W3024043772 sameAs 3024043772 @default.
• W3024043772 citedByCount "14" @default.
• W3024043772 countsByYear W30240437722020 @default.
• W3024043772 countsByYear W30240437722021 @default.
• W3024043772 countsByYear W30240437722022 @default.
• W3024043772 countsByYear W30240437722023 @default.
• W3024043772 crossrefType "journal-article" @default.
• W3024043772 hasAuthorship W3024043772A5010285605 @default.
• W3024043772 hasAuthorship W3024043772A5016492304 @default.
• W3024043772 hasAuthorship W3024043772A5019974900 @default.
• W3024043772 hasAuthorship W3024043772A5031445633 @default.
• W3024043772 hasAuthorship W3024043772A5036101233 @default.
• W3024043772 hasAuthorship W3024043772A5043523088 @default.

• next